Equillium, Inc. (EQ)
NASDAQ: EQ · Real-Time Price · USD
2.490
-0.200 (-7.43%)
At close: Jul 24, 2026, 4:00 PM EDT
2.495
+0.005 (0.20%)
After-hours: Jul 24, 2026, 7:34 PM EDT
Equillium Employees
As of December 31, 2025, Equillium had 15 total employees, including 14 full-time and 1 part-time employees. The number of employees decreased by 20 or -57.14% compared to the previous year.
Employees
15
Change (1Y)
-20
Growth (1Y)
-57.14%
Revenue / Employee
n/a
Profits / Employee
-$1,270,333
Market Cap
157.43M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 15 | -20 | -57.14% | 14 | 1 |
| Dec 31, 2024 | 35 | -9 | -20.45% | 35 | 0 |
| Sep 30, 2024 | 45 | 0 | - | 45 | 0 |
| Jun 30, 2024 | 45 | -2 | -4.26% | 45 | 0 |
| Mar 31, 2024 | 44 | 7 | 18.92% | 44 | 0 |
| Dec 31, 2023 | 44 | 8 | 22.22% | 44 | 0 |
| Sep 30, 2023 | 45 | 0 | - | 45 | 0 |
| Jun 30, 2023 | 47 | 2 | 4.44% | 47 | 0 |
| Mar 31, 2023 | 37 | -10 | -21.28% | 37 | 0 |
| Dec 31, 2022 | 36 | -9 | -20.00% | 36 | 0 |
| Sep 30, 2022 | 45 | 0 | - | 45 | 0 |
| Jun 30, 2022 | 45 | - | - | 45 | 0 |
| Mar 31, 2022 | 47 | 16 | 51.61% | 47 | 0 |
| Dec 31, 2021 | 45 | 14 | 45.16% | 45 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Tonix Pharmaceuticals Holding | 142 |
| Arcturus Therapeutics Holdings | 111 |
| Nkarta | 108 |
| Alector | 103 |
| Caribou Biosciences | 97 |
| Acumen Pharmaceuticals | 61 |
| Korro Bio | 49 |
| Camp4 Therapeutics | 48 |
EQ News
- 4 days ago - Equillium initiated with a Buy at Clear Street - TheFly
- 12 days ago - Equillium initiated with an Overweight at Piper Sandler - TheFly
- 5 weeks ago - EQ Works Expands Multi-Year Partnership with Leading Canadian Publisher to Include SaaS License for ClearLake - Accesswire
- 7 weeks ago - Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - Equillium to Participate in the 2026 Jefferies Global Healthcare Conference - GlobeNewsWire
- 2 months ago - Equillium price target raised to $7 from $6 at Raymond James - TheFly
- 2 months ago - Leerink upgrades Equillium on ‘supportive’ ulcerative colitis data - TheFly
- 2 months ago - Equillium upgraded to Outperform from Market Perform at Leerink - TheFly